Srvatra Pharma India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Srvatra Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Sud, Anshul Verma, and Varun Sud serve as directors at the Company.
- CIN/LLPIN
U52311HP2020PTC008211
- Company No.
008211
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Srvatra Pharma India Private Limited offer?
Srvatra Pharma India Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hair Shampoo, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Sexual Wellness Products, Erectile Dysfunction Medicine, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Digestive System Drugs & Medicines, Pantoprazole Drugs.
Who are the key members and board of directors at Srvatra Pharma India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Sud  | Director | 11-Nov-2020 | Current |
| Anshul Verma | Director | 11-Nov-2020 | Current |
| Varun Sud | Additional Director | 07-Jan-2022 | Current |
Financial Performance of Srvatra Pharma India.
Srvatra Pharma India Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Srvatra Pharma India?
Unlock access to Srvatra Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Srvatra Pharma India?
Unlock and access historical data on people associated with Srvatra Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srvatra Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srvatra Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
